Search

Filters

Clear Filters
3:20 PM - 3:30 PM PT

105 - Use of Gadolinium Nanoparticles as Radiosensitizers for Brain Metastases: Results from the Phase 2 Multicentric Randomized Trial (NANORAD2)
Speaker: Verry, Camille, MD - Centre Hospitalier Universitaire Grenoble Alpes, Grenoble
8:15 AM - 8:20 AM PT

1050 - Salvage Thoracic Reirradiation for Recurrent Non-Small Cell Lung Cancer: Clinical Efficacy and the Impact of Consolidative Immunotherapy
Speaker: Rocchetti, Jenna, BA - Rowan SOM, Stratford, NJ
8:20 AM - 8:25 AM PT

1051 - Efficacy and Safety of Twice-Daily (BID) Re-Irradiation (Re-RT) of Thoracic Malignancies
Speaker: Doss, Victoria, MD - Johns Hopkins Medicine, Baltimore, MD
8:25 AM - 8:30 AM PT

1052 - Comparison of Image Guided Thermal Ablation and Stereotactic Body Radiation Therapy for Primary Non-Small Cell Lung Cancer
Speaker: Nikitas, John, MD - UCLA Radiation Oncology, Los Angeles, CA
8:30 AM - 8:35 AM PT

1053 - Optimizing Blood-Based Genomic Characterization of Oligometastatic Non-Small Cell Lung Cancer Patients
Speaker: Choi, Ariel, MD - Wake Forest Baptist Medical Center, Winston Salem, NC
12:50 PM - 12:55 PM PT

1054 - Development and Prospective Validation of a Fully AI-Driven Online Adaptive Radiotherapy Workflow
Speaker: Zhou, Guan-Qun, MD, PhD - Sun Yat-Sen University Cancer Center, Guang Dong Province, Guangdong
12:55 PM - 1:00 PM PT

1055 - Implementation of Knowledge-Based Planning As a Quality Assurance Feedback Tool for a Multicentre Prostate Clinical Trial (TROG 18.01 NINJA)
Speaker: Martin, Jarad, MD, MB, ChB, PhD, BSc FRANZCR GAustMS - Calvary Mater Newcastle Hospital, Newcastle, NSW
1:00 PM - 1:05 PM PT

1056 - Vision-Language AI Model for Detecting PET/CT-Occult Lymph Node Metastasis in Early-Stage NSCLC Treated with SABR to Prevent Regional Recurrence
Speaker: Xu, Hui, PhD - MD Anderson Cancer Center, Houston, TX
1:05 PM - 1:10 PM PT

1057 - AI Automated Measures of Tumor Burden and Correlation with Pre-Treatment Circulating Tumor DNA in Head and Neck Cancer
Speaker: Bakhtiar, Mina, MD - Mass General Brigham/Massachusetts General Hospital/Harvard Med School, Boston, MA
1:10 PM - 1:15 PM PT

1058 - Reproducibility of Statistically Significant Phase III Oncology Trials: An In Silico<em> </em>Meta-Epidemiological Analysis
Speaker: Sherry, Alexander, MD - University of Texas MD Anderson Cancer Center, Houston, TX
1:15 PM - 1:20 PM PT

1059 - Multitask Double Machine Learning for Counterfactual Estimation of Survival and Toxicity in Locally Advanced Non-Small Cell Lung Cancer Chemoradiotherapy
Speaker: Lee, Sang Ho, PhD - University of Pennsylvania, Philadelphia, PA
3:30 PM - 3:40 PM PT

106 - Prospective Interventional Study Investigating the Neurocognitive Effects and Quality of Life (QOL) in Patients with Brain Metastases, Comparing Hippocampal Avoidance Whole-Brain Radiation Therapy (HA-WBRT) with SIB to SRS/FSRT
Speaker: Das, Souvik Sankar, MBBS - Chittaranjan National Cancer Institute, Kolkata, West Benga